Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine. – Logos Biosystems | Advanced Imaging Solutions for Research Excellence

Products

< Back

Customer Reviews

< Back

Resources

< Back

Support

< Back

About Us

< Back

Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine.

2013-12-22

2014. Duong HQ, Yi YW, Kang HJ, Hong YB, Tang W, Wang A, Seong YS, Bae I. International Journal of Oncology 44(3): 959-69.